Bridging the Gender Gap in Cardiovascular Medicine: Addressing Drug Intolerances and Personalized Care for Women with Angina/Ischemia with Non-Obstructive Coronary Artery Disease
2024

Bridging the Gender Gap in Cardiovascular Medicine

Sample size: 154 publication Evidence: moderate

Author Information

Author(s): McChord Johanna, Ong Peter, Brand Thomas

Primary Institution: Robert Bosch Krankenhaus, Department of Cardiology and Angiology, Stuttgart, Germany

Hypothesis

How do sex-based differences affect drug intolerances and personalized care for women with angina and non-obstructive coronary artery disease?

Conclusion

Women experience unique cardiovascular conditions and higher rates of drug intolerances, necessitating personalized treatment approaches.

Supporting Evidence

  • Women present cardiovascular diseases differently from men, often with non-obstructive coronary artery disease.
  • Up to 40% of patients with non-obstructive coronary artery disease experience refractory angina.
  • Specialized women's heart centers improve diagnosis and treatment for women with myocardial infarction and non-obstructive coronary arteries.

Takeaway

This study shows that women often have different heart problems than men and may not respond well to standard medications, so doctors need to treat them differently.

Methodology

The study involved a one-year follow-up of 154 women with non-obstructive CAD at a specialized heart center, assessing their diagnoses and treatment outcomes.

Potential Biases

Potential bias due to underrepresentation of women in clinical trials affecting treatment efficacy understanding.

Limitations

The study primarily focuses on women, which may limit generalizability to men.

Participant Demographics

The study involved 154 women diagnosed with non-obstructive coronary artery disease.

Digital Object Identifier (DOI)

10.3390/jcdd11120381

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication